<DOC>
	<DOCNO>NCT01002950</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , pharmacokinetics pharmacodynamics investigational drug ACU-4429 subject geographic atrophy .</brief_summary>
	<brief_title>Study Safety , Tolerability , Pharmacokinetics Pharmacodynamics ACU-4429 Subjects With Geographic Atrophy</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Geographic Atrophy</mesh_term>
	<criteria>Have clinical diagnosis geographic atrophy , define protocol Currently receive receive medication prohibit protocol</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>